N'-[2-(2-chlorophenyl)-2-hydroxyethyl]-N-ethyl-4-[(5-methyl-1,2-oxazol-3-yl)methyl]piperazine-1-carboximidamide

C20H28ClN5O2 — CID 111982199

IUPACN'-[2-(2-chlorophenyl)-2-hydroxyethyl]-N-ethyl-4-[(5-methyl-1,2-oxazol-3-yl)methyl]piperazine-1-carboximidamide
SMILESCCN/C(=N\CC(O)c1ccccc1Cl)N1CCN(Cc2cc(C)on2)CC1
InChIInChI=1S/C20H28ClN5O2/c1-3-22-20(23-13-19(27)17-6-4-5-7-18(17)21)26-10-8-25(9-11-26)14-16-12-15(2)28-24-16/h4-7,12,19,27H,3,8-11,13-14H2,1-2H3,(H,22,23)
InChIKeyVSIMPIKYGCVXRZ-UHFFFAOYSA-N
MW405.93 g/mol
LogP2.45
Rot. Bonds6

About N'-[2-(2-chlorophenyl)-2-hydroxyethyl]-N-ethyl-4-[(5-methyl-1,2-oxazol-3-yl)methyl]piperazine-1-carboximidamide

N'-[2-(2-chlorophenyl)-2-hydroxyethyl]-N-ethyl-4-[(5-methyl-1,2-oxazol-3-yl)methyl]piperazine-1-carboximidamide (PubChem CID 111982199) has the molecular formula C20H28ClN5O2 and a molecular weight of 405.93 g/mol. Its IUPAC name is N'-[2-(2-chlorophenyl)-2-hydroxyethyl]-N-ethyl-4-[(5-methyl-1,2-oxazol-3-yl)methyl]piperazine-1-carboximidamide.

Molecular Properties

Compound NameN'-[2-(2-chlorophenyl)-2-hydroxyethyl]-N-ethyl-4-[(5-methyl-1,2-oxazol-3-yl)methyl]piperazine-1-carboximidamide
PubChem CID111982199
Molecular FormulaC20H28ClN5O2
Molecular Weight405.93 g/mol
Exact Mass405.19
IUPAC NameN'-[2-(2-chlorophenyl)-2-hydroxyethyl]-N-ethyl-4-[(5-methyl-1,2-oxazol-3-yl)methyl]piperazine-1-carboximidamide
SMILESCCN/C(=N\CC(O)c1ccccc1Cl)N1CCN(Cc2cc(C)on2)CC1
InChIInChI=1S/C20H28ClN5O2/c1-3-22-20(23-13-19(27)17-6-4-5-7-18(17)21)26-10-8-25(9-11-26)14-16-12-15(2)28-24-16/h4-7,12,19,27H,3,8-11,13-14H2,1-2H3,(H,22,23)
InChIKeyVSIMPIKYGCVXRZ-UHFFFAOYSA-N
XLogP2.45
TPSA77.13 Ų
H-Bond Donors2
H-Bond Acceptors5
Rotatable Bonds6
Heavy Atoms28
Complexity

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500405.93
LogP ≤ 52.45
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 105

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'imine_1', 'substructure': 'N/A'}, {'alert_name': 'imine_2', 'substructure': 'N/A'}

Analyze N'-[2-(2-chlorophenyl)-2-hydroxyethyl]-N-ethyl-4-[(5-methyl-1,2-oxazol-3-yl)methyl]piperazine-1-carboximidamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of N'-[2-(2-chlorophenyl)-2-hydroxyethyl]-N-ethyl-4-[(5-methyl-1,2-oxazol-3-yl)methyl]piperazine-1-carboximidamide?
The IUPAC name of N'-[2-(2-chlorophenyl)-2-hydroxyethyl]-N-ethyl-4-[(5-methyl-1,2-oxazol-3-yl)methyl]piperazine-1-carboximidamide (CID 111982199) is N'-[2-(2-chlorophenyl)-2-hydroxyethyl]-N-ethyl-4-[(5-methyl-1,2-oxazol-3-yl)methyl]piperazine-1-carboximidamide.
What is the SMILES notation for N'-[2-(2-chlorophenyl)-2-hydroxyethyl]-N-ethyl-4-[(5-methyl-1,2-oxazol-3-yl)methyl]piperazine-1-carboximidamide?
The canonical SMILES for N'-[2-(2-chlorophenyl)-2-hydroxyethyl]-N-ethyl-4-[(5-methyl-1,2-oxazol-3-yl)methyl]piperazine-1-carboximidamide is CCN/C(=N\CC(O)c1ccccc1Cl)N1CCN(Cc2cc(C)on2)CC1.
What is the InChIKey of N'-[2-(2-chlorophenyl)-2-hydroxyethyl]-N-ethyl-4-[(5-methyl-1,2-oxazol-3-yl)methyl]piperazine-1-carboximidamide?
The InChIKey is VSIMPIKYGCVXRZ-UHFFFAOYSA-N. The full InChI is InChI=1S/C20H28ClN5O2/c1-3-22-20(23-13-19(27)17-6-4-5-7-18(17)21)26-10-8-25(9-11-26)14-16-12-15(2)28-24-16/h4-7,12,19,27H,3,8-11,13-14H2,1-2H3,(H,22,23).
What are the key properties of N'-[2-(2-chlorophenyl)-2-hydroxyethyl]-N-ethyl-4-[(5-methyl-1,2-oxazol-3-yl)methyl]piperazine-1-carboximidamide?
N'-[2-(2-chlorophenyl)-2-hydroxyethyl]-N-ethyl-4-[(5-methyl-1,2-oxazol-3-yl)methyl]piperazine-1-carboximidamide has a molecular weight of 405.93 g/mol, XLogP of 2.45, 6 rotatable bonds, 2 hydrogen bond donors, and 5 hydrogen bond acceptors.
Where does this data come from?
All data for N'-[2-(2-chlorophenyl)-2-hydroxyethyl]-N-ethyl-4-[(5-methyl-1,2-oxazol-3-yl)methyl]piperazine-1-carboximidamide is sourced from PubChem (CID 111982199), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).